Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.59 |
| ▸ | BRD2 | P25440 | 1/20 | 0.59 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | APEX1 | P27695 | 2/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30762 | 0.89 | — | — | |
| Methane SCHEMBL27440503 | 0.87 | PIK3CD (0.47) | PIK3CDTSHRKMT2ACHRM2CHRM5 | |
| Ammonia Solution, Strong SCHEMBL28118769 | 0.87 | PIK3CD (0.47) | PIK3CDTSHRKMT2ACHRM2CHRM5 | |
| Hydrochloric Acid SCHEMBL7162864 | 0.87 | PIK3CD (0.47) | PIK3CDTSHRKMT2ACHRM2CHRM5 | |
| Ammonia Solution, Strong SCHEMBL11155607 | 0.85 | PIK3CD (0.46) | PIK3CDTSHRKMT2ACHRM2CHRM5 | |
| SCHEMBL15846768 | 0.84 | PIK3CD (0.46) | PIK3CDTSHRKMT2ACHRM2CHRM5 | |
| SCHEMBL2574923 | 0.83 | L3MBTL1 (0.44) | PIK3CDTSHRKMT2ACHRM2CHRM5 | |
| SCHEMBL284047 | 0.82 | L3MBTL1 (0.47) | PIK3CDTSHRKMT2ACHRM2CHRM5 | |
| Ether SCHEMBL22771109 | 0.81 | PIK3CD (0.43) | PIK3CDTSHRKMT2ACHRM2CHRM5 | |
| SCHEMBL29212561 | 0.81 | PIK3CD (0.42) | PIK3CDTSHRKMT2ACHRM2CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2961268-B1 | SAMPLE FIXATION AND STABILISATION | GOLDSBOROUGH ANDREW SIMON (FR) | 2018-11-21 | — | — | EP | claimed |
| EP-2383258-B1 | METHOD FOR RAPIDLY METHYLATING HETEROAROMATIC ARENE AND METHOD FOR PRODUCING PET TRACER | RIKEN (JP) | 2015-09-02 | — | — | EP | claimed |
| EP-0603418-B1 | HERBICIDE COMPOSITION | KUMIAI CHEMICAL INDUSTRY CO (JP) | 1997-06-18 | — | — | EP | claimed |
| EP-0531292-B1 | PHOTORESIST STRIPPER | IBM (US) | 1997-01-02 | — | — | EP | claimed |
| EP-0075784-B1 | PROCESS FOR DIRECT GOLD PLATING OF STAINLESS STEEL | Kobayashi, Masami (JP) | 1986-12-03 | — | — | EP | claimed |
| US-20210393596-A1 | DRUG FOR TREATING TINNITUS | SCOTT, LUISA LYNN | 2021-12-23 | — | — | US | disclosed |
| CN-107198686-B | Antifungal medicine composition | 宝丽制药股份有限公司 | 2019-07-30 | — | — | CN | disclosed |
| CN-208632439-U | Electronic equipment framework | DIC株式会社 | 2019-03-22 | — | — | CN | disclosed |
| CN-104662046-A | Method for producing modified conjugated diene polymer, polymer composition, crosslinked polymer, and tire | JSR CORP | 2015-05-27 | — | — | CN | disclosed |
| CN-104487460-A | Method for producing modified conjugated diene polymer, polymer composition, crosslinked polymer, and tire | JSR CORP | 2015-04-01 | — | — | CN | disclosed |
| WO-2014102305-A1 | METHOD FOR PURIFYING A RECYCLING FLOW FROM A PLANT FOR PRODUCING POLYARYLENE ETHER SULFONES | BASF SE (DE) | 2014-07-03 | — | — | WO | disclosed |
| WO-2014102306-A2 | METHOD FOR PURIFYING A RECYCLING FLOW FROM A PLANT FOR PRODUCING POLYARYLENE ETHER SULFONES | BASF SE (DE) | 2014-07-03 | — | — | WO | disclosed |
| EP-1231877-A4 | TRANSDERMAL ADMINISTRATION OF HUPERZINE | XEL HERBACEUTICALS (US) | 2009-03-18 | — | — | EP | disclosed |
| CN-101171551-A | Composition for removing post etch and ashed photoresist residue and bulk photoresist | MALLINCKRODT BAKER INC (US) | 2008-04-30 | — | — | CN | disclosed |
| US-6896898-B1 | Transdermal delivery system for alkaloids of aconitum species | XEL HERBACEUTICALS, INC. (US) | 2005-05-24 | — | — | US | disclosed |
| US-20040202705-A1 | Transdermal administration of huperzine | XEL HERBACEUCTICALS, INC. | 2004-10-14 | — | — | US | disclosed |
| US-6585963-B1 | Nail compositions and methods of administering same | WATSON PHARMACEUTICALS, INC. | 2003-07-01 | — | — | US | disclosed |
| EP-1231877-A1 | TRANSDERMAL ADMINISTRATION OF HUPERZINE | XEL Herbaceuticals (US) | 2002-08-21 | — | — | EP | disclosed |
| WO-2001035883-A1 | TRANSDERMAL DELIVERY SYSTEM FOR ALKALOIDS OF ACONITUM SPECIES | XEL HERBACEUTICALS (US) | 2001-05-25 | — | — | WO | disclosed |
| WO-2001032115-A1 | TRANSDERMAL ADMINISTRATION OF HUPERZINE | XEL HERBACEUTICALS (US) | 2001-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210393596-A1 | DRUG FOR TREATING TINNITUS | CHAT, SLC18A2, TRPV1 | BRD4 1210/4885BRD2 2951/4885PIK3CD 3511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.